Adhil Shetty, Vikas Garg, and Naveen Kulkarni opine on the RBI MPC policy, and how it would affect market sentiment, and pave the way for economic growth.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale